Quest Diagnostics
DGX
#1076
Rank
โ‚ฌ15.73 B
Marketcap
141,40ย โ‚ฌ
Share price
1.50%
Change (1 day)
19.57%
Change (1 year)
Quest Diagnostics is an American clinical laboratory company offering access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders and employment and court ordered drug testing.

Quest Diagnostics (DGX) - Total assets

Total assets on the balance sheet as of June 2024 : โ‚ฌ12.52 B

According to Quest Diagnostics 's latest financial reports the company's total assets are โ‚ฌ12.52 B. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Quest Diagnostics - Total assets on balance sheet (from 2001 to 2024)

Total assets by year

Year Total assets Change
2023-12-31โ‚ฌ12.68 B5.99%
2022-12-31โ‚ฌ11.96 B0.03%
2021-12-31โ‚ฌ11.96 B4.27%
2020-12-31โ‚ฌ11.47 B0.32%
2019-12-31โ‚ฌ11.43 B19.08%
2018-12-31โ‚ฌ9.60 B9.73%
2017-12-31โ‚ฌ8.75 B-8.84%
2016-12-31โ‚ฌ9.60 B5.23%
2015-12-31โ‚ฌ9.12 B12.69%
2014-12-31โ‚ฌ8.09 B25.02%
2013-12-31โ‚ฌ6.47 B-7.79%
2012-12-31โ‚ฌ7.02 B-2.05%
2011-12-31โ‚ฌ7.17 B11.58%
2010-12-31โ‚ฌ6.42 B7.45%
2009-12-31โ‚ฌ5.98 B0.42%
2008-12-31โ‚ฌ5.95 B2.52%
2007-12-31โ‚ฌ5.81 B35.41%
2006-12-31โ‚ฌ4.29 B-4.21%
2005-12-31โ‚ฌ4.47 B61.1%
2004-12-31โ‚ฌ2.78 B-19.26%
2003-12-31โ‚ฌ3.44 B8.29%
2002-12-31โ‚ฌ3.17 B-4.17%
2001-12-31โ‚ฌ3.31 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
โ‚ฌ15.08 B 20.40%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ10.06 M-99.92%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ1.48 B-88.16%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ84.34 M-99.33%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ5.03 B-59.77%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands